Scientists developing vaccines and anti-tick treatments amid growing concern over spread of disease
Cases of Lyme disease have risen more than 20% in England in the past year, public health experts have revealed, as pharmaceutical companies work to create new vaccines and drugs to tackle the tick-borne illness.
According to data from the UK Health Security Agency (UKHSA), published as part of its One Health vector-borne disease surveillance report, there were 1,168 laboratory-confirmed cases of Lyme disease in 2025, up from 959 in 2024 – an increase of 22%. However, the figure is similar to that recorded in 2023, when there were 1,151 confirmed cases.
Continue reading...This article was originally published by The Guardian and written by Nicola Davis Science correspondent.
Read original article on The Guardian